Select Medical Holdings Co. (NYSE:SEM) Shares Acquired by Rhumbline Advisers

Rhumbline Advisers lifted its position in Select Medical Holdings Co. (NYSE:SEM) by 0.2% in the fourth quarter, Holdings Channel reports. The firm owned 316,502 shares of the health services provider’s stock after acquiring an additional 635 shares during the period. Rhumbline Advisers’ holdings in Select Medical were worth $5,966,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in SEM. Geode Capital Management LLC increased its holdings in shares of Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after purchasing an additional 46,880 shares during the period. Principal Financial Group Inc. grew its position in Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after buying an additional 147,032 shares during the last quarter. Point72 Asset Management L.P. increased its stake in Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after buying an additional 1,216,263 shares during the period. Charles Schwab Investment Management Inc. raised its position in Select Medical by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after buying an additional 24,439 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Select Medical by 0.6% in the 3rd quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock worth $41,184,000 after acquiring an additional 7,372 shares during the period. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 17.50% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research note on Monday. UBS Group cut their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Finally, Royal Bank of Canada decreased their target price on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $27.25.

Select Medical Stock Performance

Shares of SEM stock opened at $18.50 on Thursday. The company’s fifty day simple moving average is $19.07 and its 200-day simple moving average is $27.71. The company has a market cap of $2.39 billion, a PE ratio of 11.21, a P/E/G ratio of 0.64 and a beta of 1.45. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical Holdings Co. has a 52 week low of $16.20 and a 52 week high of $40.98.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, February 20th. The health services provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, equities research analysts anticipate that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd will be paid a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date of this dividend is Monday, March 3rd. Select Medical’s dividend payout ratio is presently 15.15%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.